Word

AKTERLI

Status

Dead

Status Code

602

Status Date

Monday, August 28, 2023

Serial Number

97623309

Mark Type

4000

Filing Date

Friday, October 7, 2022

Abandoned Date

Monday, August 14, 2023

Trademark Owner History

Kalvista Pharmaceuticals Limited

Classifications

5 (Based on Intent to Use) Pharmaceutical preparations for the treatment of angioedema; Pharmaceutical preparations for the treatment of hereditary angioedema; Pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; Pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; Pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders; Pharmaceutical preparations for containing sebetralstat; Pharmaceutical preparations for containing feniralstat(Based on 44(d) Priority Application) Pharmaceutical preparations for the treatment of angioedema; Pharmaceutical preparations for the treatment of hereditary angioedema; Pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; Pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; Pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders; Pharmaceutical preparations for containing sebetralstat; Pharmaceutical preparations for containing feniralstat

Trademark Events

Aug 29, 2023

Abandonment Notice E-Mailed - Failure To Respond

Aug 28, 2023

Abandonment Notice Mailed - Failure To Respond

Aug 28, 2023

Abandonment - Failure To Respond Or Late Response

May 12, 2023

Notification Of Non-Final Action E-Mailed

May 12, 2023

Non-Final Action E-Mailed

May 12, 2023

Non-Final Action Written

May 5, 2023

Assigned To Examiner

Oct 24, 2022

New Application Office Supplied Data Entered

Oct 11, 2022

New Application Entered